MIS
CRL icon

Morningstar Investment Services’s Charles River Laboratories CRL Stock Holding History

Morningstar Investment Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$394K Sell
2,616
-2,300
-47% -$386K 0.07% 124
2024
Q4 		$907K Sell
4,916
-58,744
-92% -$11.3M 0.08% 115
2024
Q3 		$12.6M Buy
63,660
+352
+0.6% +$73.2K 0.13% 119
2024
Q2 		$13.1M Sell
63,308
-561
-0.9% -$127K 0.14% 116
2024
Q1 		$17.2M Sell
63,869
-38,757
-38% -$9.26M 0.19% 106
2023
Q4 		$24.5M Buy
102,626
+51,110
+99% +$10.1M 0.14% 116
2023
Q3 		$10.1M Buy
51,516
+1,148
+2% +$236K 0.13% 118
2023
Q2 		$10.5M Buy
50,368
+43,112
+594% +$8.58M 0.14% 118
2023
Q1 		$1.44M Buy
7,256
+601
+9% +$136K 0.02% 161
2022
Q4 		$1.47M Buy
6,655
+220
+3% +$48K 0.02% 152
2022
Q3 		$1.34M Buy
+6,435
New +$1.39M 0.02% 150
2014
Q1 		– Sell
-30,122
Closed -$1.6M – 204
2013
Q4 		$1.6M Buy
30,122
+159
+0.5% +$7.99K 0.12% 133
2013
Q3 		$1.4M Sell
29,963
-1,200
-4% -$55.1K 0.12% 130
2013
Q2 		$1.28M Buy
+31,163
New +$1.34M 0.13% 115

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morningstar Investment Services's CRL Position: Q1 2025 in Review

Morningstar Investment Services reduced its Charles River Laboratories (CRL) stake by 47% in Q1 2025, selling an estimated $386K and leaving 2,616 shares worth $394K. The position accounts for 0.07% of the portfolio, ranked #124.

Morningstar Investment Services first reported a position in CRL in Q2 2013 and has held it in 14 quarters since. The position peaked at $24.5M in Q4 2023. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Morningstar Investment Services held 2,616 shares of Charles River Laboratories worth $394K as of Q1 2025.
  • Morningstar Investment Services sold 2,300 Charles River Laboratories shares in Q1 2025, an estimated $386K.
  • Charles River Laboratories made up 0.07% of Morningstar Investment Services's portfolio in Q1 2025, its #124 holding.
  • Morningstar Investment Services first reported a position in Charles River Laboratories in Q2 2013 and has held it in 14 quarters since.
  • Morningstar Investment Services's Charles River Laboratories position peaked at $24.5M in Q4 2023.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Morningstar Investment Services's 13F filing for Q1 2025, filed 5 May 2025.